Teyro Labs Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 30.00 Cr
as on 03-07-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 154.02 Cr
as on 03-07-2024
- Revenue -19.92%
(FY 2023)
- Profit -1982.86%
(FY 2023)
- Ebitda -187.35%
(FY 2023)
- Net Worth -40.30%
(FY 2023)
- Total Assets 9.47%
(FY 2023)
About Teyro Labs
The Corporate was formerly known as Accencis Health Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 30.00 Cr.
The company currently has active open charges totaling ₹154.02 Cr.
The Key Managerial Personnel (KMP) at Teyro Labs Private Limited India is Harsh Jhunjhunwala as COMPANY SECRETARY. Sundeep Jegathrakshagan and Jagathrakshakan Swamikannu serve as directors at the Company.
- CIN/LLPIN
U24100TN2014PTC095150
- Company No.
095150
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Teyro Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harsh Jhunjhunwala | Company Secretary | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sundeep Jegathrakshagan  | Director | 01-Dec-2014 | Current |
| Jagathrakshakan Swamikannu | Director | 21-Feb-2014 | Current |
Financial Performance and Corporate Structure Insights of Teyro Labs.
Teyro Labs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.92% decrease. The company also saw a substantial fall in profitability, with a 1982.86% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Teyro Labs?
In 2023, Teyro Labs had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jasan Infra Private LimitedActive 8 years 9 monthsSundeep Jegathrakshagan and Jagathrakshakan Swamikannu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Nov 2016 | ₹154.02 Cr | Open |
How Many Employees Work at Teyro Labs?
Teyro Labs has a workforce of 175 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Teyro Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Teyro Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
